HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Acutrim, Allerest Extensions Focus On Natural Ingredients

This article was originally published in The Tan Sheet

Executive Summary

New Acutrim Natural, a "dietary supplement and weight loss system" extension to the appetite suppressant line, contains no ephedrine, is drug-free and causes no side effects, according to marketer Heritage Consumer Products.

You may also be interested in...



Acutrim

Health & Nutrition Systems International expects to book revenue by the end of March from its January acquisition of three Acutrim trademarks and outstanding inventory of two natural "ephedrine-free" appetite suppressant formulations for $180,000 from Heritage Brands/Insight Pharmaceuticals. West Palm Beach, Fla.-based HNS, which markets weight management and body building products such as Carb Cutter, Thin Tab and Carbolizer in gyms, health food stores and drug chains, purchased only the inventory for Acutrim Natural A.M. and P.M., which launched last June (1"The Tan Sheet" May 15, 2000, p. 7). Heritage pulled original Acutrim formulas from the market after FDA's November request that companies voluntarily halt marketing PPA-containing products. The Acutrim franchise has lost market share in recent years to ephedrine alkaloid-containing supplements

Weight-Loss Segment Future Uncertain With PPA Actions, Ephedra Questions

FDA actions discouraging the use of phenylpropanolamine-containing products will further accelerate the recent shift away from the OTC appetite suppressant ingredient toward ephedra supplements.

PPA-Free Cough/Cold, Appetite Suppressant Formulations Planned

Novartis Consumer Health anticipates launching Tavist Allergy/Sinus/Headache caplets in time for the spring allergy season.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133037

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel